Literature DB >> 20650542

Geminin expression in small lung adenocarcinomas: implication of prognostic significance.

Tomohiro Haruki1, Kohei Shomori, Yuki Hamamoto, Yuji Taniguchi, Hiroshige Nakamura, Hisao Ito.   

Abstract

Geminin is an important molecule which plays a role in cell cycle regulation, and this has been considered to be a useful biomarker of cell proliferation. The purpose of this study was to evaluate the pathological and prognostic significance of geminin expression in small lung adenocarcinoma (AC). We performed Western blot analysis of five human lung AC cell lines and immunohistochemistry on 100 surgically resected specimens of lung AC with a diameter less than 3 cm. We counted the number of positively stained tumor cells, and calculated the labeling indices (LIs). Geminin proteins were variably detected in all five cell lines examined on Western blotting. The mean LIs for geminin, Ki-67, and MCM7 were 7.5%, 12.3%, and 18.5%, respectively. The geminin LIs were associated with some clinicopathological profiles including gender, histological grade, subtypes, N-status, p-factor, and tumor stage. A significantly worse prognosis was noted in the higher geminin LIs group than in the lower group (p < 0.01). Multivariate Cox regression analysis also confirmed that geminin LIs was an independent prognostic marker in stage IA lung AC patients. These results suggest that geminin is overexpressed in small lung ACs, and geminin LIs might be a useful prognostic indicator in patients with lung AC.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650542     DOI: 10.1016/j.lungcan.2010.06.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

Review 1.  Regulation of geminin by neuropeptide Y in vascular smooth muscle cell proliferation : A current review.

Authors:  S-Y Liang; Y-L Zhou; M-Q Shu; S Lin
Journal:  Herz       Date:  2018-08-27       Impact factor: 1.443

Review 2.  Research status and funding trends of lung cancer biomarkers.

Authors:  Cui Li; Wei Hong
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

3.  Evaluation of NUF2 and GMNN Expression in Prostate Cancer: Potential Biomarkers for Prostate Cancer Screening.

Authors:  Shaghayegh Pezeshki; Payam Hashemi; Alireza Salimi; Sheida Ebrahimi; Mandana Javanzad; Amir Monfaredan
Journal:  Rep Biochem Mol Biol       Date:  2021-07

4.  Spotlight on geminin.

Authors:  Melvin L DePamphilis
Journal:  Breast Cancer Res       Date:  2011-06-01       Impact factor: 6.466

5.  Geminin overexpression promotes imatinib sensitive breast cancer: a novel treatment approach for aggressive breast cancers, including a subset of triple negative.

Authors:  Zannel Blanchard; Nicole Mullins; Pavani Ellipeddi; Janice M Lage; Shawn McKinney; Rana El-Etriby; Xu Zhang; Raphael Isokpehi; Brenda Hernandez; Wael M Elshamy
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

6.  MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions.

Authors:  Bonnie Choy; Amy LaLonde; Jianwen Que; Tongtong Wu; Zhongren Zhou
Journal:  Hum Pathol       Date:  2016-07-29       Impact factor: 3.466

7.  Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues.

Authors:  Yan Xing; Chaojun Wang; Jie Wu
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

8.  Expression of Minichromosome Maintenance Proteins (MCM) and Cancer Prognosis: A meta-analysis.

Authors:  Kaihua Gou; Jingwei Liu; Xue Feng; Hao Li; Yuan Yuan; Chengzhong Xing
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.